The scientific literature on COVID-19 is rapidly evolving and these articles were selected for review based on their relevance to Washington State decision making around COVID-19 response efforts. Included in these Lit Reps are some manuscripts that have been made available online as pre-prints but have not yet undergone peer review. Please be aware of this when reviewing articles included in the Lit Reps.<\/p>\n
Today’s summary is based on a review of 626 articles (587 published, 39 in preprint)<\/em><\/p>\n View the PDF version here.<\/a><\/strong><\/p>\n \t\t\t\t<\/p>\n Kuwelker et al.\u00a0(Mar 31, 2021). Attack Rates amongst Household Members of Outpatients with Confirmed COVID-19 in Bergen, Norway: A Case-Ascertained Study. The Lancet Regional Health – Europe. <\/span><\/i>https:\/\/doi.org\/10.1016\/j.lanepe.2020.100014<\/span><\/a><\/p>\n<\/p>\n<\/div>\n \t\t\t\t\t\t\t\t\t<\/p>\n<\/div>\n<\/div>\n<\/div>\n \t\t\t\t<\/p>\n Bennett-Guerrero et al.\u00a0(Apr 16, 2021). Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York. Critical Care Medicine. <\/span><\/i>https:\/\/doi.org\/10.1097\/CCM.0000000000005066<\/span><\/a><\/p>\n<\/p>\n<\/div>\n \t\t\t\t\t\t\t\t\t<\/p>\n<\/div>\n<\/div>\n<\/div>\n \t\t\t\t<\/p>\n Yang et al.\u00a0(Apr 19, 2021). Serological Investigation of Asymptomatic Cases of SARS-CoV-2 Infection Reveals Weak and Declining Antibody Responses. Emerging Microbes & Infections. <\/span><\/i>https:\/\/doi.org\/10.1080\/22221751.2021.1919032<\/span><\/a><\/p>\n<\/p>\n<\/div>\n \t\t\t\t\t\t\t\t\t<\/p>\n<\/div>\n \t\t\t\t<\/p>\n Goepfert et al.\u00a0(Apr 19, 2021). Safety and Immunogenicity of SARS-CoV-2 Recombinant Protein Vaccine Formulations in Healthy Adults: Interim Results of a Randomised, Placebo-Controlled, Phase 1\u20132, Dose-Ranging Study. The Lancet Infectious Diseases. <\/span><\/i>https:\/\/doi.org\/10.1016\/S1473-3099(21)00147-X<\/span><\/a><\/p>\n<\/p>\n<\/div>\n \t\t\t\t\t\t\t\t\t<\/p>\n<\/div>\n \t\t\t\t<\/p>\n Demmer et al.\u00a0(Apr 19, 2021). Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies among Vaccinated Populations. Pre-print downloaded Apr 20 from <\/span><\/i>https:\/\/doi.org\/10.1101\/2021.04.12.21255330<\/span><\/a><\/p>\n<\/p>\n<\/div>\n \t\t\t\t\t\t\t\t\t<\/p>\n<\/div>\n<\/div>\n<\/div>\n \t\t\t\t<\/p>\n Godfred-Cato et al.\u00a0(Apr 16, 2021). Multisystem Inflammatory Syndrome in Infants <12 Months of Age, United States, May 2020\u2013January 2021. Pediatric Infectious Disease Journal. <\/span><\/i>https:\/\/doi.org\/10.1097\/INF.0000000000003149<\/span><\/a><\/p>\n<\/p>\n<\/div>\n \t\t\t\t\t\t\t\t\t<\/p>\n<\/div>\n \t\t\t\t<\/p>\n Abdallah et al.\u00a0(Apr 19, 2021). Symptoms, Pulmonary Function and Functional Capacity Four Months after COVID-19. Annals of the American Thoracic Society. <\/span><\/i>https:\/\/doi.org\/10.1513\/AnnalsATS.202012-1489RL<\/span><\/a><\/p>\n<\/p>\n<\/div>\n \t\t\t\t\t\t\t\t\t<\/p>\n<\/div>\n<\/div>\n<\/div>\n \t\t\t\t<\/p>\n \u00a0<\/span>Smith et al.\u00a0(Apr 17, 2021). Substance Use and Mental Health in Pregnant Women during the COVID-19 Pandemic. Journal of Reproductive and Infant Psychology. <\/span><\/i>https:\/\/doi.org\/10.1080\/02646838.2021.1916815<\/span><\/a><\/p>\n<\/p>\n<\/div>\n \t\t\t\t\t\t\t\t\t<\/p>\n<\/div>\n<\/div>\n<\/div>\n \t\t\t\t<\/p>\n Freitas et al.\u00a0(Apr 19, 2021). The Increase in the Risk of Severity and Fatality Rate of Covid-19 in Southern Brazil after the Emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 Was Greater among Young Adults without Pre-Existing Risk Conditions. Pre-print downloaded Apr 20 from <\/span><\/i>https:\/\/doi.org\/10.1101\/2021.04.13.21255281<\/span><\/a><\/p>\n<\/p>\n<\/div>\n \t\t\t\t\t\t\t\t\t<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n Report prepared by the UW Alliance for Pandemic Preparedness and Global Health Security and the START Center in collaboration with and on behalf of WA DOH COVID-19 Incident Management Team<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":" In Brazil, younger patients without pre-existing conditions accounted for a larger proportion of severe COVID-19 cases leading to death in the second wave of cases (February 2021) compared to the first wave (November-December 2020). The second wave was predominated by the P.1 variant. <\/p>\nKey Takeaways<\/h2>\n
\n
\n
Article Summaries<\/h3>\n
Transmission<\/span><\/h2>\n
Attack Rates amongst Household Members of Outpatients with Confirmed COVID-19 in Bergen, Norway: A Case-Ascertained Study<\/h5>\n
\n
Testing and Treatment<\/span><\/h2>\n
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York<\/h5>\n
\n
Vaccines and Immunity<\/h2>\n
Serological Investigation of Asymptomatic Cases of SARS-CoV-2 Infection Reveals Weak and Declining Antibody Responses<\/h5>\n
\n
Safety and Immunogenicity of SARS-CoV-2 Recombinant Protein Vaccine Formulations in Healthy Adults: Interim Results of a Randomised, Placebo-Controlled, Phase 1\u20132, Dose-Ranging Study<\/h5>\n
\n
Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies among Vaccinated Populations<\/h5>\n
\n
Clinical Characteristics and Health Care Setting<\/span><\/h2>\n
Multisystem Inflammatory Syndrome in Infants <12 Months of Age, United States, May 2020\u2013January 2021<\/h5>\n
\n
Symptoms, Pulmonary Function and Functional Capacity Four Months after COVID-19<\/h5>\n
\n
Mental Health and Personal Impact<\/span><\/h2>\n
Substance Use and Mental Health in Pregnant Women during the COVID-19 Pandemic<\/h5>\n
\n
Public Health Policy and Practice<\/span><\/h2>\n
The Increase in the Risk of Severity and Fatality Rate of Covid-19 in Southern Brazil after the Emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 Was Greater among Young Adults without Pre-Existing Risk Conditions<\/h5>\n
\n
Other Resources and Commentaries<\/h2>\n
\n